According to Stratistics MRC, the Global Sterilization Technologies Market is accounted for $8.06 billion in 2017 and is expected to reach $14.93 billion by 2026 growing at a CAGR of 7.1%. Some of the key factors influencing the market growth include increasing prevalence of various diseases such as cancer and tuberculosis, increasing demand of sterilization in various industries such as the food industry and rise in number of hospital acquired infections (HAI). However, stringent regulations associated with harmful gases, high cost of sterilization equipment & devices are some factors restricting the market growth.

Sterilization Technologies are the processes used to decrease the growth of all feasible life forms such as bacteria, viruses, fungi, and spore forms from the surfaces of equipment, food ingredients, biological culture medium etc. Sterilization makes sure nontoxic products for human expenditure and commercial processes. Sterilization services are probable to witness the fastest growth in the sterilization technology market and are categorized into contract sterilization services and sterilization validation services.

By End User, Medical devices sterilization accounted for considerable market share during period. It requires sterilization as it prevents the growth and distribution of further infections to the patients. If unsterilized equipment is used, it can cause an infection and may require surgery upon exposure and can lead to further complications. By Geography, The Asia-Pacific market has been experiencing significant growth owing to rising aging population, increasing healthcare expenses, rising pharmaceutical trade in the region, high pollution levels, and increasing medical tourism.

Some of the key players in global Sterilization Technologies market include Johnson & Johnson, Sterigenics International, LLC, Atec Pharmatechnik GmbH, Sterile Technologies Inc., 3M Company, Anderson Products, Inc., Steris Plc, In Vitro Technologies, Matachana Group, Advanced Sterilization Products (ASP), Donaldson Co. Inc, Getinge AB, Beta Star Life Science Equipment Inc, Belimed AG, Ethicon, Inc., Noxilizer, Inc., TSO3 Inc. and CISA Group.

Types Covered:

  • Thermal Sterilization
  • Filtration Sterilization
  • Ionization Radiation Sterilization
  • Chemical & Gas Sterilization
  • Devices
  • Consumables
  • Services



Processes Covered:

  • Physical Processes
  • Physicochemical
  • Chemical Process
  • Synergetic Processes



Applications Covered:

  • Pharmaceutical sterilization
  • Medical devices sterilization



End Users Covered:

  • Manufacturing
  • Agriculture
  • Medical Devices
  • Cosmetic
  • Food & Beverage
  • Pharmaceutical & biotechnology companies
  • Hospitals & Clinics
  • Ambulatory surgical centers
  • Academic and research organizations
  • Other End Users



Regions Covered:

  • North America
  • ·US
  • ·Canada
  • ·Mexico
  • Europe
  • ·Germany
  • ·UK
  • ·Italy
  • ·France
  • ·Spain
  • ·Rest of Europe
  • Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Australia
  • ·New Zealand
  • ·South Korea
  • ·Rest of Asia Pacific
  • South America
  • ·Argentina
  • ·Brazil
  • ·Chile
  • ·Rest of South America
  • Middle East & Africa
  • ·Saudi Arabia
  • ·UAE
  • ·Qatar
  • ·South Africa
  • ·Rest of Middle East & Africa



What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements